Latest News and Press Releases

Det gennemsnitlige HbA1c-niveau ved studiets begyndelse var mellem 8,0% og 8,5%, og ved studiets afslutning havde mere end 50% af patienterne i liraglutide-gruppen nået det blodsukkermål, American...

Novo Nordisk today announced clinical results from the first of five phase 3 studies with liraglutide - the once-daily human GLP-1 analogue. The 26-week study is part of the LEAD(TM) (Liraglutide...

Den 24. mai 2007 kjøpte Yara Nederland B.V. og den finske Stat solgte 17.188.480 aksjer i Kemira GrowHow Oyj ("Kemira GrowHow) tilsvarende om lag 30,05 prosent av alle utstedte aksjer og...

On 24 May 2007 Yara Nederland B.V. purchased and the Republic of Finland sold 17,188,480 shares in Kemira GrowHow Oyj ("Kemira GrowHow") corresponding to approximately 30.05 percent of all the issued...

This announcement is not for release, publication or distribution in the United States, Canada, Australia or Japan. This announcement is not an offer of securities for sale in the United States or...

YARA INTERNATIONAL ASA STOCK EXCHANGE RELEASE 21 June 2007 09:00 a.m. YARA INTERNATIONAL ASA TO MAKE MANDATORY TENDER OFFER FOR ALL SHARES IN KEMIRA GROWHOW OYJ THROUGH ITS...

(Oslo, 21. juni 2007): - Klagenemda for eierskap i media ser ut til å bli neste adresse i Media Norge-prosessen. Under et møte med Medietilsynet onsdag morgen ble det klart for oss at en minnelig...

(Oslo, 20.06.07): After two negotiation meetings, Schibsted and the other Media Norge companies do not expect that the negotiations will lead to any solutions. The Norwegian Media authority is...

A total number of 43.690 new shares in Kemira Oyj have been subscribed on the basis of the stock option rights granted under the stock option program of the year 2001. In accordance with the...

Kemira Oyj:n vuoden 2001 optio-ohjelmaan liittyvillä optio-oikeuksilla on merkitty yhteensä 43 690 uutta Kemiran osaketta. Optioehtojen mukaisesti osakkeiden merkintähinta oli 16.4.2007 mennessä...